Public Value proposition
Better understanding towards better therapeutics in #Cancer, #Infection & #Inflammation - @IpbsToulouse
The Institute of Pharmacology and Structural Biology (Institut de Pharmacologie et de Biologie Structurale, IPBS) is a joint CNRS-University of Toulouse research center occupying 12,000 m2 at the heart of the campus of Paul Sabatier University.
The IPBS currently has a scientific and administrative staff of 250 people, including a large number of postdoctoral workers and postgraduate (masters and PhD) students, working in 16 research teams grouped into three departments (Cancer Biology, Structural Biology and Biophysics, Tuberculosis and Infection Biology), and four technological platforms.
Our institute is a world leader in the discovery, characterization and validation of novel important pathways and therapeutic targets in the fields of cancer and infectious diseases, through the use of molecular and cellular biology approaches, together with in vivo experiments, including BSL-3-based studies of infectious diseases.
It conducts state-of-the-art research in structural biology, proteomics, biophysics, cancerology, immunology and microbiology.
Cancer biology, Infectious Diseases, Structural Biology and Biophysics, and Therapeutic TargetOriginal language
Better understanding towards better therapeutics in #Cancer, #Infection & #Inflammation - @IpbsToulouse
The Institute of Pharmacology and Structural Biology (Institut de Pharmacologie et de Biologie Structurale, IPBS) is a joint CNRS-University of Toulouse research center occupying 12,000 m2 at the heart of the campus of Paul Sabatier University.
The IPBS currently has a scientific and administrative staff of 250 people, including a large number of postdoctoral workers and postgraduate (masters and PhD) students, working in 16 research teams grouped into three departments (Cancer Biology, Structural Biology and Biophysics, Tuberculosis and Infection Biology), and four technological platforms.
Our institute is a world leader in the discovery, characterization and validation of novel important pathways and therapeutic targets in the fields of cancer and infectious diseases, through the use of molecular and cellular biology approaches, together with in vivo experiments, including BSL-3-based studies of infectious diseases.
It conducts state-of-the-art research in structural biology, proteomics, biophysics, cancerology, immunology and microbiology.
Home - IPBS-Toulouse
The primary objective of the Institute of Pharmacology and Structural Biology is the identification, characterization and exploitation of novel therapeutic targets in the fields of Cancer, Infection and Inflammation.
https://www.ipbs.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 CNRS Research, Research Services | CNRS Research, Research Services | Other 11 Feb 2022 23 Mar 2024 | | |
 MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 19 Nov 2019 | | |
 United Nations International development, International Affairs | United Nations International development, International Affairs | Other 22 Apr 2021 | | |
 Toulouse Métropole Government Administration, French metropolis | Toulouse Métropole Government Administration, French metropolis | Other 1 May 2021 | | |
 La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | La Région Occitanie / Pyrénées-Méditerranée National and local authorities, Government Administration | Other 23 Mar 2024 | | |
 Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Other 15 Oct 2021 | | |
 CEA Research | CEA Research | Other 21 Oct 2020 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 28 Sep 2023 | | |